Bellus Health Competitors and Similar CompaniesClear all
Bellus Health's competitors and similar companies include Moderna, Regeneron Pharmaceuticals, Quantum Hi-Tech (China) Biological and Fortrea.
 Bellus Health Bellus Health is a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. |  Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine. |  Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines. |  Fortrea Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO). | ||
Founding Date | Founding Date 2010 | Founding Date 2010 | Founding Date 1988 | Founding Date 2000 | Founding Date 2023 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Laval, CA HQ | Locations Tarrytown, US HQ Mississauga, CA Courbevoie, FR München, DE Bengaluru, IN Dublin, IE Limerick, IE see more | Locations Guang Zhou Shi, CN HQ | Locations Durham, US HQ Buenos Aires, AR Melbourne, AU Sydney, AU Zaventem, BE Sao Paulo, BR Sofia, BG see more | |
Employees | Employees 7485% increase | Employees 5,8004% increase | Employees 15,1068% increase | Employees 1,814 | Employees 19,000 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 21.2 b | Valuation ($) 102.2 b | Valuation ($) N/A | Valuation ($) 1.6 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $16k (FY, 2022) | Revenue (est.) $1.9b (FY, 2025) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) ¥1.1b (FY, 2025) | Revenue (est.) $2.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $868m (FY, 2025) | Cost of goods N/A | Cost of goods ¥810m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $507k (FY, 2022) | Gross profit $1.1b (FY, 2025) | Gross profit N/A | Gross profit ¥320.9m (FY, 2025) | Gross profit N/A |
Net income | Net income ($76.1m) (FY, 2022) | Net income ($2.8b) (FY, 2025) | Net income $4.5b (FY, 2025) | Net income ¥13.6m (FY, 2025) | Net income ($986.2m) (FY, 2025) |
Operating ⚠ | |||||
Patents (US) | Patents (US) N/A | Patents (US) 170 (FY, 2021) | Patents (US) 31 (FY, 2020) | Patents (US) N/A | Patents (US) N/A |
Funding | |||||
Total funding raised | Total funding raised $ 49.3m | Total funding raised $ 1.8b | Total funding raised $ 53.9m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Moderna
HQ
Cambridge, US
Employees
5,800↑ 4% increase
Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
View companyRegeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
15,106↑ 8% increase
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
View company
Quantum Hi-Tech (China) Biological
HQ
Guang Zhou Shi, CN
Employees
1,814
Quantum Hi-Tech (China) Biological is a biotechnology company.
View companyFortrea
HQ
Durham, US
Employees
19,000
Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO).
View company